TRUSELTIQ
- Product NDC
- 72730-506
- 11-digit product format
- 727300506
- Labeler code
- 72730
- Product ID
- 72730-506_0529ba94-9541-4ce3-8b59-0afb1e44e0f1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- infigratinib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- QED Therapeutics, Inc.
- Application
- NDA214622
- Marketing category
- NDA
- Marketing start
- 2021-05-28
- Marketing end
- 0000-00-00
- Substance
- INFIGRATINIB
- Active strength
- 50 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72730-506 | TRUSELTIQ (INFIGRATINIB) CAPSULE [QED THERAPEUTICS, INC.] | 3 | Legacy NDC | 20220211_af9a96cf-1cd7-8ace-e053-2a95a90a18cc.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72730-506-01 | 72730050601 | 1 BLISTER PACK in 1 CARTON (72730-506-01) > 42 CAPSULE in 1 BLISTER PACK | 1 blister pack | 2021-05-28 | 0000-00-00 | No | No | Current |